Xtandi Pricing and Patents: Alternatives To March-In Urged To Lower Medicare, Medicaid Costs

 
• By Cathy Kelly
  
CMS asked to accelerate generic competition To Xtandi

More from Legal & IP

More from Generics Bulletin